ArticleHuman vaccines & immunotherapeutics2017

Targeting the gram-negative bacteria peptidoglycan synthase MraY as a new approach for monoclonal antibody anti-bacterial activity.

Jun Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.